Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Isabel A. Lefevre"'
Autor:
Kina Höglund, Nathalie Schussler, Hlin Kvartsberg, Una Smailovic, Gunnar Brinkmalm, Victor Liman, Bruno Becker, Henrik Zetterberg, Angel Cedazo-Minguez, Shorena Janelidze, Isabel A. Lefevre, Stéphanie Eyquem, Oskar Hansson, Kaj Blennow
Publikováno v:
Neurobiology of Disease, Vol 134, Iss , Pp - (2020)
Synapse impairment is thought to be an early event in Alzheimer's disease (AD); dysfunction and loss of synapses are linked to cognitive symptoms that precede neuronal loss and neurodegeneration. Neurogranin (Ng) is a somatodendritic protein that has
Externí odkaz:
https://doaj.org/article/2a2166a0818947feb47ea5f79bda33ee
Autor:
Anton Bespalov, René Bernard, Anja Gilis, Björn Gerlach, Javier Guillén, Vincent Castagné, Isabel A Lefevre, Fiona Ducrey, Lee Monk, Sandrine Bongiovanni, Bruce Altevogt, María Arroyo-Araujo, Lior Bikovski, Natasja de Bruin, Esmeralda Castaños-Vélez, Alexander Dityatev, Christoph H Emmerich, Raafat Fares, Chantelle Ferland-Beckham, Christelle Froger-Colléaux, Valerie Gailus-Durner, Sabine M Hölter, Martine CJ Hofmann, Patricia Kabitzke, Martien JH Kas, Claudia Kurreck, Paul Moser, Malgorzata Pietraszek, Piotr Popik, Heidrun Potschka, Ernesto Prado Montes de Oca, Leonardo Restivo, Gernot Riedel, Merel Ritskes-Hoitinga, Janko Samardzic, Michael Schunn, Claudia Stöger, Vootele Voikar, Jan Vollert, Kimberley E Wever, Kathleen Wuyts, Malcolm R MacLeod, Ulrich Dirnagl, Thomas Steckler
Publikováno v:
eLife, Vol 10 (2021)
While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union’s Innovative Medicines Initiative, the EQIPD conso
Externí odkaz:
https://doaj.org/article/056d0e1179a847c792213de97e872285
Autor:
Björn Gerlach, Ernesto Prado Montes de Oca, Alexander Dityatev, Thomas Steckler, Merel Ritskes-Hoitinga, Gernot Riedel, Valerie Gailus-Durner, Patricia Kabitzke, Janko Samardzic, Claudia Stöger, Lior Bikovski, Raafat Fares, Martine C J Hofmann, Chantelle Ferland-Beckham, Sabine M. Hölter, Claudia Kurreck, Leonardo Restivo, Natasja de Bruin, Christoph H. Emmerich, Vootele Voikar, Michael Schunn, Małgorzata Pietraszek, Sandrine Bongiovanni, Heidrun Potschka, Piotr Popik, Kathleen Wuyts, Christelle Froger-Colléaux, Isabel A Lefevre, Fiona Ducrey, Malcolm R. Macleod, Jan Vollert, Kimberley E. Wever, Anja Gilis, Vincent Castagné, Javier Guillén, Anton Bespalov, Paul Moser, Esmeralda Castaños-Vélez, Martien J H Kas, René Bernard, María Arroyo-Araujo, Ulrich Dirnagl, Bruce Altevogt, Lee Monk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc90a26852dc14f02daa4f94e0442e0
https://doi.org/10.7554/elife.63294.sa2
https://doi.org/10.7554/elife.63294.sa2
Autor:
Lior Bikovski, Raafat Fares, Anton Bespalov, Claudia Kurreck, Leonardo Restivo, Paul Moser, Chantelle Ferland-Beckham, Claudia Stöger, Patricia Kabitzke, Ernesto Prado Montes de Oca, Bruce Altevogt, Valerie Gailus-Durner, Sabine M. Hölter, Piotr Popik, Martine C J Hofmann, Vootele Voikar, Lee Monk, Michael Schunn, Alexander Dityatev, Janko Samardzic, Gernot Riedel, Thomas Steckler, Natasja de Bruin, Merel Ritskes-Hoitinga, Kathleen Wuyts, Christoph H. Emmerich, Heidrun Potschka, Vincent Castagné, Christelle Froger-Colléaux, Fiona Ducrey, Anja Gilis, Björn Gerlach, Jan Vollert, Kimberley E. Wever, Sandrine Bongiovanni, Esmeralda Castaños-Vélez, Martien J H Kas, René Bernard, Malcolm R. Macleod, Isabel A Lefevre, Javier Guillén, Małgorzata Pietraszek, María Arroyo-Araujo, Ulrich Dirnagl
Publikováno v:
Bespalov, A, Bernard, R, Gilis, A, Gerlach, B, Guillén, J, Castagné, V, Lefevre, I A, Ducrey, F, Monk, L, Bongiovanni, S, Altevogt, B, Arroyo-araujo, M, Bikovski, L, De Bruin, N, Castaños-vélez, E, Dityatev, A, Emmerich, C H, Fares, R, Ferland-beckham, C, Froger-colléaux, C, Gailus-durner, V, Hölter, S M, Hofmann, M C, Kabitzke, P, Kas, M J, Kurreck, C, Moser, P, Pietraszek, M, Popik, P, Potschka, H, Prado Montes De Oca, E, Restivo, L, Riedel, G, Ritskes-hoitinga, M, Samardzic, J, Schunn, M, Stöger, C, Voikar, V, Vollert, J, Wever, K E, Wuyts, K, Macleod, M R, Dirnagl, U & Steckler, T 2021, ' Introduction to the EQIPD quality system ', eLIFE, vol. 10 . https://doi.org/10.7554/eLife.63294
eLife, 10:e63294. ELIFE SCIENCES PUBLICATIONS LTD
eLife, Vol 10 (2021)
eLife 10, e63294 (2021). doi:10.7554/eLife.63294
eLife
Elife, 10
Bespalov, A, Bernard, R, Gilis, A, Gerlach, B, Guillén, J, Castagné, V, Lefevre, I A, Ducrey, F, Monk, L, Bongiovanni, S, Altevogt, B, Arroyo-Araujo, M, Bikovski, L, de Bruin, N, Castaños-Vélez, E, Dityatev, A, Emmerich, C H, Fares, R, Ferland-Beckham, C, Froger-Colléaux, C, Gailus-Durner, V, Hölter, S M, Hofmann, M C, Kabitzke, P, Kas, M J, Kurreck, C, Moser, P, Pietraszek, M, Popik, P, Potschka, H, Prado Montes de Oca, E, Restivo, L, Riedel, G, Ritskes-Hoitinga, M, Samardzic, J, Schunn, M, Stöger, C, Voikar, V, Vollert, J, Wever, K E, Wuyts, K, MacLeod, M R, Dirnagl, U & Steckler, T 2021, ' Introduction to the EQIPD quality system ', eLife, vol. 10, e63294 . https://doi.org/10.7554/eLife.63294
eLife, vol. 10, pp. e63294
eLife, 10:e63294. ELIFE SCIENCES PUBLICATIONS LTD
eLife, Vol 10 (2021)
eLife 10, e63294 (2021). doi:10.7554/eLife.63294
eLife
Elife, 10
Bespalov, A, Bernard, R, Gilis, A, Gerlach, B, Guillén, J, Castagné, V, Lefevre, I A, Ducrey, F, Monk, L, Bongiovanni, S, Altevogt, B, Arroyo-Araujo, M, Bikovski, L, de Bruin, N, Castaños-Vélez, E, Dityatev, A, Emmerich, C H, Fares, R, Ferland-Beckham, C, Froger-Colléaux, C, Gailus-Durner, V, Hölter, S M, Hofmann, M C, Kabitzke, P, Kas, M J, Kurreck, C, Moser, P, Pietraszek, M, Popik, P, Potschka, H, Prado Montes de Oca, E, Restivo, L, Riedel, G, Ritskes-Hoitinga, M, Samardzic, J, Schunn, M, Stöger, C, Voikar, V, Vollert, J, Wever, K E, Wuyts, K, MacLeod, M R, Dirnagl, U & Steckler, T 2021, ' Introduction to the EQIPD quality system ', eLife, vol. 10, e63294 . https://doi.org/10.7554/eLife.63294
eLife, vol. 10, pp. e63294
While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Numerous analyses conducted to date have clearly identified measures that need to be take
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aef7c0ead5b242adb59f95192215766
http://hdl.handle.net/10044/1/95909
http://hdl.handle.net/10044/1/95909
Autor:
Merel Ritskes-Hoitinga, Ulrich Dirnagl, Malcolm Macleod, Thomas Steckler, Jan Vollert, Esther Schenker, Anton Bespalov, Hanno Wuerbel, Heidrun Potschka, Kimberley E Wever, Bruce Altevogt, Andrew S C Rice, Judi Clark, Emily Sena, Bruno Boulanger, Gernot Riedel, Bettina Platt, Annesha Sil, Martien J Kas, Bernhard Voelkl, Mathias Jucker, Bettina M Wegenast-braun, René Bernard, Esmeralda Heiden, Ann-marie Waldron, Maarten Loos, Pim Drinkenburg, Juan Diego Pita almenar, David Gallacher, Anja Gilis, Greet Teuns, Karsten Wicke, Sabine Grote, Bernd Sommer, Janet Nicholson, Sanna Janhunen, Sami Virtanen, Kristin Cheng, Sylvie Ramboz, Emer Leahy, Isabel A Lefevre, Fiona Ducrey, Javier Guillen, Patri Vergara, Kimberley Wever, Martin Michel, Tom van de Casteele, Martin C Michel, Tom Van De Casteele, Henk Van Der Linde, Isabel Seiffert
Publikováno v:
BMJ Open Science, Vol 4, Iss 1 (2020)
Over the last two decades, awareness of the negative repercussions of flaws in the planning, conduct and reporting of preclinical research involving experimental animals has been growing. Several initiatives have set out to increase transparency and
Autor:
Anton Bespalov, Rene Bernard, Björn Gerlach, Christoph Emmerich, Malgorzata Pietraszek, Isabel Ann Lefevre, Esmeralda Castaños-Vélez, Alexander Dityatev, Patricia Kabitzke, Claudia Kurreck, Gernot Riedel, Jan Vollert, Kimberley Wever, Ulrich Dirnagl, Malcolm Macleod
While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Numerous analyses conducted to date have clearly identified measures that need to be take
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df004194c1156caa3cba6d32b445b77b
https://doi.org/10.31219/osf.io/ng32b
https://doi.org/10.31219/osf.io/ng32b
Publikováno v:
Good Research Practice in Non-Clinical Pharmacology and Biomedicine
Handbook of Experimental Pharmacology
Handbook of Experimental Pharmacology-Good Research Practice in Non-Clinical Pharmacology and Biomedicine
Good Research Practice in Non-Clinical Pharmacology and Biomedicine ISBN: 9783030336554
Handbook of Experimental Pharmacology
Handbook of Experimental Pharmacology-Good Research Practice in Non-Clinical Pharmacology and Biomedicine
Good Research Practice in Non-Clinical Pharmacology and Biomedicine ISBN: 9783030336554
Thousands of pharmacology experiments are performed each day, generating hundreds of drug discovery programs, scientific publications, grant submissions, and other efforts. Discussions of the low reproducibility and robustness of some of this researc
Publikováno v:
Handbook of experimental pharmacology. 257
Thousands of pharmacology experiments are performed each day, generating hundreds of drug discovery programs, scientific publications, grant submissions, and other efforts. Discussions of the low reproducibility and robustness of some of this researc
Autor:
Thomas Steckler, Jan Vollert, Esther Schenker, Anton Bespalov, Hanno Wuerbel, Martin Christian Michel, Heidrun Potschka, Kimberley E Wever, Bruce Altevogt, Andrew S C Rice, Judi Clark, Bruno Boulanger, Gernot Riedel, Bettina Platt, Annesha Sil, Martien J Kas, Bernhard Voelkl, Mathias Jucker, Bettina M Wegenast-braun, René Bernard, Esmeralda Heiden, Ann-marie Waldron, Maarten Loos, Tom Van De casteele, Pim Drinkenburg, Juan Diego Pita almenar, David Gallacher, Henk Van Der linde, Anja Gilis, Greet Teuns, Karsten Wicke, Sabine Grote, Bernd Sommer, Janet Nicholson, Sanna Janhunen, Sami Virtanen, Kristin Cheng, Sylvie Ramboz, Emer Leahy, Isabel A Lefevre, Fiona Ducrey, Javier Guillen, Patri Vergara, Thomas Ingraham
Publikováno v:
BMJ Open Science
BMJ Open Science, Vol 2, Iss 1 (2018)
Vollert, J, Schenker, E, Macleod, M, Bespalov, A, Wuerbel, H, Michel, M C, Dirnagl, U, Potschka, H, Wever, K E, Steckler, T, Altevogt, B & Rice, A S C 2018, ' Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals ', BMJ Open Science, vol. 2, no. 1, pp. e000004 . https://doi.org/10.1136/bmjos-2018-000004
Vollert, Jan; Schenker, Esther; Macleod, Malcolm; Bespalov, Anton; Würbel, Hanno; Michel, Martin Christian; Dirnagl, Ulrich; Potschka, Heidrun; Wever, Kimberley E; Steckler, Thomas; Altevogt, Bruce; Rice, Andrew S C (2018). Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals. BMJ open science, 2(1), e000004. BMJ Publishing Group 10.1136/bmjos-2018-000004
BMJ Open Science, Vol 2, Iss 1 (2018)
Vollert, J, Schenker, E, Macleod, M, Bespalov, A, Wuerbel, H, Michel, M C, Dirnagl, U, Potschka, H, Wever, K E, Steckler, T, Altevogt, B & Rice, A S C 2018, ' Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals ', BMJ Open Science, vol. 2, no. 1, pp. e000004 . https://doi.org/10.1136/bmjos-2018-000004
Vollert, Jan; Schenker, Esther; Macleod, Malcolm; Bespalov, Anton; Würbel, Hanno; Michel, Martin Christian; Dirnagl, Ulrich; Potschka, Heidrun; Wever, Kimberley E; Steckler, Thomas; Altevogt, Bruce; Rice, Andrew S C (2018). Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals. BMJ open science, 2(1), e000004. BMJ Publishing Group 10.1136/bmjos-2018-000004
Objective Within the last years, there has been growing awareness of the negative repercussions of unstandardized planning, conduct and reporting of preclinical and biomedical research. Several initiatives have set the aim of increasing validity and
Autor:
Thomas Licher, Daniel Bertrand, Jean-Marie Chambard, Isabel A. Lefevre, Bruno Biton, Michel Partiseti, Christophe Lanneau
Publikováno v:
Current Protocols in Pharmacology
Over the last six decades, voltage-gated sodium (Nav ) channels have attracted a great deal of scientific and pharmaceutical interest, driving fundamental advances in both biology and technology. The structure and physiological function of these chan